| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 4.49e-07 | 9 | 36 | 3 | GO:0015379 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 1.17e-06 | 12 | 36 | 3 | GO:0008519 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 9.30e-06 | 23 | 36 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | cholesterol O-acyltransferase activity | 9.47e-06 | 3 | 36 | 2 | GO:0034736 | |
| GeneOntologyMolecularFunction | sterol O-acyltransferase activity | 9.47e-06 | 3 | 36 | 2 | GO:0004772 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.36e-05 | 26 | 36 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.38e-05 | 125 | 36 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.53e-04 | 151 | 36 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.47e-04 | 171 | 36 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA binding | 7.14e-04 | 22 | 36 | 2 | GO:0000062 | |
| GeneOntologyMolecularFunction | fatty acid derivative binding | 8.51e-04 | 24 | 36 | 2 | GO:1901567 | |
| GeneOntologyMolecularFunction | acyl-CoA binding | 9.99e-04 | 26 | 36 | 2 | GO:0120227 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.28e-03 | 119 | 36 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | channel activity | 2.37e-03 | 525 | 36 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.39e-03 | 526 | 36 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | symporter activity | 2.47e-03 | 150 | 36 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.35e-03 | 167 | 36 | 3 | GO:0015079 | |
| GeneOntologyMolecularFunction | cholesterol binding | 4.90e-03 | 58 | 36 | 2 | GO:0015485 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 5.07e-03 | 59 | 36 | 2 | GO:0008374 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 1.16e-06 | 13 | 34 | 3 | GO:0072488 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 9.18e-06 | 25 | 34 | 3 | GO:0055064 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 1.30e-05 | 28 | 34 | 3 | GO:0055081 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 1.58e-05 | 4 | 34 | 2 | GO:0140157 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 3.06e-05 | 37 | 34 | 3 | GO:0055075 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 3.37e-05 | 112 | 34 | 4 | GO:1902476 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 4.50e-05 | 42 | 34 | 3 | GO:0006884 | |
| GeneOntologyBiologicalProcess | chloride transport | 5.68e-05 | 128 | 34 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 6.79e-05 | 134 | 34 | 4 | GO:0098661 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 8.07e-05 | 51 | 34 | 3 | GO:1990573 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.14e-04 | 153 | 34 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle clearance | 1.52e-04 | 63 | 34 | 3 | GO:0034381 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 2.12e-04 | 180 | 34 | 4 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.26e-04 | 183 | 34 | 4 | GO:0006820 | |
| GeneOntologyBiologicalProcess | hypotonic response | 2.37e-04 | 14 | 34 | 2 | GO:0006971 | |
| GeneOntologyBiologicalProcess | very-low-density lipoprotein particle assembly | 2.37e-04 | 14 | 34 | 2 | GO:0034379 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 2.78e-04 | 357 | 34 | 5 | GO:0009101 | |
| GeneOntologyBiologicalProcess | regulation of plasma lipoprotein particle levels | 6.47e-04 | 103 | 34 | 3 | GO:0097006 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 6.50e-04 | 430 | 34 | 5 | GO:0009100 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation | 6.84e-04 | 105 | 34 | 3 | GO:0006493 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 7.56e-04 | 252 | 34 | 4 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 7.56e-04 | 252 | 34 | 4 | GO:0006486 | |
| GeneOntologyBiologicalProcess | cholesterol storage | 8.36e-04 | 26 | 34 | 2 | GO:0010878 | |
| GeneOntologyBiologicalProcess | glycosylation | 9.78e-04 | 270 | 34 | 4 | GO:0070085 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle assembly | 1.04e-03 | 29 | 34 | 2 | GO:0034377 | |
| GeneOntologyBiologicalProcess | protein-lipid complex assembly | 1.35e-03 | 33 | 34 | 2 | GO:0065005 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.64e-03 | 142 | 34 | 3 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.64e-03 | 142 | 34 | 3 | GO:0098659 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 7.24e-04 | 1293 | 33 | 8 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 7.47e-04 | 1299 | 33 | 8 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 8.59e-04 | 1327 | 33 | 8 | GO:0042175 | |
| Domain | GAGE | GAGE4 GAGE5 GAGE6 GAGE12H GAGE1 GAGE13 GAGE12F GAGE12I GAGE2E | 4.60e-19 | 24 | 40 | 9 | PF05831 |
| Domain | GAGE_fam | GAGE4 GAGE5 GAGE6 GAGE12H GAGE1 GAGE13 GAGE12F GAGE12I GAGE2E | 7.17e-19 | 25 | 40 | 9 | IPR008625 |
| Domain | GAGE | 3.95e-10 | 19 | 40 | 5 | SM01379 | |
| Domain | GAGE | 3.95e-10 | 19 | 40 | 5 | IPR031320 | |
| Domain | KCL_cotranspt | 3.63e-08 | 4 | 40 | 3 | IPR000076 | |
| Domain | SLC12A_fam | 3.17e-07 | 7 | 40 | 3 | IPR004842 | |
| Domain | SLC12 | 5.06e-07 | 8 | 40 | 3 | PF03522 | |
| Domain | SLC12_C | 5.06e-07 | 8 | 40 | 3 | IPR018491 | |
| Domain | Sterol_acyltranf_meta | 4.47e-06 | 2 | 40 | 2 | IPR030687 | |
| Domain | KCC1 | 4.47e-06 | 2 | 40 | 2 | IPR000622 | |
| Domain | Oat_ACAT_DAG_ARE | 1.34e-05 | 3 | 40 | 2 | IPR014371 | |
| Domain | AA-permease/SLC12A_dom | 1.36e-05 | 22 | 40 | 3 | IPR004841 | |
| Domain | AA_permease | 1.36e-05 | 22 | 40 | 3 | PF00324 | |
| Domain | MBOAT_fam | 2.43e-04 | 11 | 40 | 2 | IPR004299 | |
| Domain | MBOAT | 2.43e-04 | 11 | 40 | 2 | PF03062 | |
| Domain | Nucleotide-diphossugar_trans | 1.52e-02 | 88 | 40 | 2 | IPR029044 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.15e-07 | 7 | 22 | 3 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.15e-07 | 7 | 22 | 3 | MM15081 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 4.98e-06 | 681 | 22 | 8 | MM14985 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 8.84e-06 | 736 | 22 | 8 | M27287 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 1.18e-04 | 62 | 22 | 3 | MM14686 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 2.07e-04 | 75 | 22 | 3 | M27032 | |
| Pathway | KEGG_STEROID_BIOSYNTHESIS | 3.12e-04 | 17 | 22 | 2 | M5872 | |
| Pathway | REACTOME_LDL_CLEARANCE | 3.50e-04 | 18 | 22 | 2 | MM15565 | |
| Pathway | REACTOME_LDL_CLEARANCE | 3.91e-04 | 19 | 22 | 2 | M27846 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.06e-04 | 108 | 22 | 3 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.22e-04 | 109 | 22 | 3 | MM15074 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 1.27e-03 | 34 | 22 | 2 | MM15566 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 1.50e-03 | 37 | 22 | 2 | M27847 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 2.41e-03 | 47 | 22 | 2 | M39853 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 2.94e-03 | 52 | 22 | 2 | MM15920 | |
| Pubmed | An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members. | GAGE4 GAGE5 GAGE6 GAGE7 GAGE12H GAGE1 GAGE13 GAGE12F GAGE12I GAGE2E | 3.78e-25 | 20 | 42 | 10 | 18179644 |
| Pubmed | 2.65e-19 | 10 | 42 | 7 | 9651357 | ||
| Pubmed | Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. | 7.27e-19 | 11 | 42 | 7 | 10397259 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | GAGE5 GAGE6 GAGE7 GAGE12G GAGE1 GAGE13 GAGE12F GAGE12I GAGE2E | 1.92e-14 | 119 | 42 | 9 | 28625976 |
| Pubmed | 2.52e-13 | 9 | 42 | 5 | 7544395 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 12637262 | ||
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 9.13e-08 | 8 | 42 | 3 | 21613606 | |
| Pubmed | 9.13e-08 | 8 | 42 | 3 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 9.13e-08 | 8 | 42 | 3 | 24393035 | |
| Pubmed | 1.37e-07 | 9 | 42 | 3 | 19323993 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 30871606 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 17510708 | ||
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 1.42e-06 | 2 | 42 | 2 | 34031912 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 18269457 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 15992359 | ||
| Pubmed | Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine. | 1.42e-06 | 2 | 42 | 2 | 22811412 | |
| Pubmed | Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. | 1.42e-06 | 2 | 42 | 2 | 26982734 | |
| Pubmed | Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. | 1.42e-06 | 2 | 42 | 2 | 14729857 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 16647063 | ||
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 1.42e-06 | 2 | 42 | 2 | 31835175 | |
| Pubmed | Organization of human ACAT-2 gene and its cell-type-specific promoter activity. | 1.42e-06 | 2 | 42 | 2 | 11401500 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 18000807 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 15158756 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 16230498 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 2.48e-06 | 22 | 42 | 3 | 18391953 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 22252133 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 31352162 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 9756920 | ||
| Pubmed | Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family. | 4.27e-06 | 3 | 42 | 2 | 12739168 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 11551954 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 15262997 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 35274823 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 4.27e-06 | 3 | 42 | 2 | 21733850 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 20133765 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 15308631 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 22669916 | ||
| Pubmed | Cellular pregnenolone esterification by acyl-CoA:cholesterol acyltransferase. | 8.53e-06 | 4 | 42 | 2 | 22474282 | |
| Pubmed | Sites of regulated phosphorylation that control K-Cl cotransporter activity. | 1.42e-05 | 5 | 42 | 2 | 19665974 | |
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 28647557 | ||
| Pubmed | 2.98e-05 | 7 | 42 | 2 | 15813942 | ||
| Pubmed | 3.97e-05 | 8 | 42 | 2 | 9756919 | ||
| Pubmed | 3.97e-05 | 8 | 42 | 2 | 12386165 | ||
| Pubmed | Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. | 5.10e-05 | 9 | 42 | 2 | 14532115 | |
| Pubmed | 9.32e-05 | 12 | 42 | 2 | 27782176 | ||
| Pubmed | 1.28e-04 | 407 | 42 | 5 | 15772651 | ||
| Pubmed | 1.69e-04 | 16 | 42 | 2 | 22632726 | ||
| Pubmed | CECR2 is involved in spermatogenesis and forms a complex with SNF2H in the testis. | 2.95e-04 | 21 | 42 | 2 | 22154806 | |
| Pubmed | 3.42e-04 | 504 | 42 | 5 | 34432599 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 8.80e-04 | 621 | 42 | 5 | 22794259 | |
| Interaction | FLT3 interactions | GAGE5 GAGE6 GAGE7 GAGE12G GAGE1 GAGE13 GAGE12F GAGE12I GAGE2E | 9.64e-09 | 318 | 40 | 9 | int:FLT3 |
| Interaction | ERLEC1 interactions | 5.26e-06 | 128 | 40 | 5 | int:ERLEC1 | |
| Interaction | CLGN interactions | 6.50e-06 | 235 | 40 | 6 | int:CLGN | |
| Interaction | GMCL1 interactions | 1.29e-05 | 154 | 40 | 5 | int:GMCL1 | |
| Interaction | ENTREP1 interactions | 2.51e-05 | 86 | 40 | 4 | int:ENTREP1 | |
| Interaction | LYPD6 interactions | 3.79e-05 | 33 | 40 | 3 | int:LYPD6 | |
| Interaction | GMCL2 interactions | 4.94e-05 | 36 | 40 | 3 | int:GMCL2 | |
| Interaction | GAGE12G interactions | 8.02e-05 | 7 | 40 | 2 | int:GAGE12G | |
| Interaction | OR10S1 interactions | 1.07e-04 | 8 | 40 | 2 | int:OR10S1 | |
| Cytoband | Xp11.23 | 3.30e-12 | 95 | 42 | 7 | Xp11.23 | |
| Cytoband | Xp11.4-p11.2 | 9.06e-12 | 6 | 42 | 4 | Xp11.4-p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 1.20e-06 | 377 | 42 | 6 | chrXp11 | |
| Cytoband | 2q37.3 | 2.29e-03 | 77 | 42 | 2 | 2q37.3 | |
| GeneFamily | Solute carriers | 8.95e-03 | 395 | 20 | 3 | 752 | |
| CoexpressionAtlas | stomach | 8.18e-06 | 160 | 37 | 5 | stomach | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Htr1a_(Neuron.Slc17a6.Htr1a)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.27e-07 | 67 | 35 | 4 | be6853b5bf254063f02a4c478fd4c3fef68cb77a | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Htr1a_(Neuron.Slc17a6.Htr1a)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.27e-07 | 67 | 35 | 4 | 7483b85423d9d07b01b60927d0fe1b7ccb241d7f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-07 | 193 | 35 | 5 | 6a9bce5064938b5b84ad57b4fd4a7841afe100c8 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 189 | 35 | 4 | e11998c57609c5714705713ac3a32016d6d841dd | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 193 | 35 | 4 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 193 | 35 | 4 | 5a92697430f16c49e19a5f727d289d7bd1ece31c | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 193 | 35 | 4 | 64bcdbb422f8da6fc3275e82f6aaf562f546a180 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 193 | 35 | 4 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 194 | 35 | 4 | 0241b4b88d6210b4c1b8aa99db17115b18142f01 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 194 | 35 | 4 | 0797245ebfa389a6f66874cb0f11297f1456e600 | |
| Drug | Potassium Chloride | 9.26e-08 | 6 | 39 | 3 | DB00761 | |
| Drug | N-methylisatoic anhydride | 5.53e-07 | 10 | 39 | 3 | CID000025160 | |
| Drug | etiroxate | 7.59e-07 | 11 | 39 | 3 | CID000065683 | |
| Drug | DCPIB | 7.59e-07 | 11 | 39 | 3 | CID010071166 | |
| Drug | 2-methyl-2,4-pentanediol | 9.71e-07 | 196 | 39 | 6 | CID000007870 | |
| Drug | indene | 1.87e-06 | 120 | 39 | 5 | CID000007219 | |
| Drug | AC1Q6A3R | 2.86e-06 | 2 | 39 | 2 | CID000160583 | |
| Drug | gypsetin | 2.86e-06 | 2 | 39 | 2 | CID000160406 | |
| Drug | glisoprenin B | 2.86e-06 | 2 | 39 | 2 | CID006438769 | |
| Drug | NSC292654 | 2.86e-06 | 2 | 39 | 2 | CID000325064 | |
| Drug | 23-methyl-UDCA | 2.86e-06 | 2 | 39 | 2 | CID000196679 | |
| Drug | 7,7-difluorocholestanol | 2.86e-06 | 2 | 39 | 2 | CID000196646 | |
| Drug | 6,6-difluorocholestanol | 2.86e-06 | 2 | 39 | 2 | CID000196647 | |
| Drug | Aplus | 2.86e-06 | 2 | 39 | 2 | CID000028221 | |
| Drug | Ro 16-0521 | 2.86e-06 | 2 | 39 | 2 | CID000065657 | |
| Drug | AC1NT076 | 2.86e-06 | 2 | 39 | 2 | CID005321102 | |
| Drug | xymedon | 2.86e-06 | 2 | 39 | 2 | CID000121931 | |
| Drug | lifibrol | 3.11e-06 | 17 | 39 | 3 | CID000057112 | |
| Drug | dalcetrapib | 8.04e-06 | 23 | 39 | 3 | CID006918540 | |
| Drug | olean-12-ene | 8.57e-06 | 3 | 39 | 2 | CID000612780 | |
| Drug | Purpactin A | 8.57e-06 | 3 | 39 | 2 | CID000131673 | |
| Drug | glisoprenin A | 8.57e-06 | 3 | 39 | 2 | CID006438768 | |
| Drug | Nsc692258 | 8.57e-06 | 3 | 39 | 2 | CID000469167 | |
| Drug | ethyl 6-chlorochroman-2-carboxylate | 8.57e-06 | 3 | 39 | 2 | CID000169516 | |
| Drug | zaragozic acid D3 | 8.57e-06 | 3 | 39 | 2 | CID006475792 | |
| Drug | Cgs-26214 | 1.71e-05 | 4 | 39 | 2 | CID000133077 | |
| Drug | AC1L3QAA | 1.71e-05 | 4 | 39 | 2 | CID000093484 | |
| Drug | isochromophilone VII | 1.71e-05 | 4 | 39 | 2 | CID006443571 | |
| Drug | isochromophilone VIII | 1.71e-05 | 4 | 39 | 2 | CID006443572 | |
| Drug | acaterin | 1.71e-05 | 4 | 39 | 2 | CID000126830 | |
| Drug | trichlormethiazide | 2.23e-05 | 32 | 39 | 3 | CID000005560 | |
| Drug | Bumetanide | 2.85e-05 | 5 | 39 | 2 | DB00887 | |
| Drug | NSC-110264 | 2.85e-05 | 5 | 39 | 2 | CID000269324 | |
| Drug | SCH 48461 | 4.27e-05 | 6 | 39 | 2 | CID000132832 | |
| Drug | TRAM-34 | 5.47e-05 | 43 | 39 | 3 | CID000656734 | |
| Drug | IPEM | 5.97e-05 | 7 | 39 | 2 | CID000126238 | |
| Drug | CP-113,818 | 7.95e-05 | 8 | 39 | 2 | CID000164373 | |
| Drug | 4-methylumbelliferyl elaidate | 7.95e-05 | 8 | 39 | 2 | CID000087585 | |
| Drug | arjunolic acid | 7.95e-05 | 8 | 39 | 2 | CID000073641 | |
| Drug | benzenesulfonyl fluoride | 8.11e-05 | 49 | 39 | 3 | CID000067779 | |
| Drug | cetyl ether | 1.02e-04 | 9 | 39 | 2 | CID000077757 | |
| Drug | propanoyl | 1.02e-04 | 9 | 39 | 2 | CID000139982 | |
| Drug | PD138142-15 | 1.02e-04 | 9 | 39 | 2 | CID003025787 | |
| Drug | sulfamate | 1.08e-04 | 54 | 39 | 3 | CID000005987 | |
| Drug | stearoylcarnitine | 1.28e-04 | 10 | 39 | 2 | CID000005282 | |
| Drug | AC1L1ICP | 1.28e-04 | 10 | 39 | 2 | CID000004520 | |
| Drug | cyclandelate | 1.56e-04 | 11 | 39 | 2 | CID000002893 | |
| Drug | acetylshikonin | 1.56e-04 | 11 | 39 | 2 | CID000032464 | |
| Drug | rubidium | 1.56e-04 | 61 | 39 | 3 | CID000105153 | |
| Drug | etofibrate | 1.87e-04 | 12 | 39 | 2 | CID000065777 | |
| Drug | AC1L4EWU | 1.87e-04 | 12 | 39 | 2 | CID000155754 | |
| Drug | 4-thiouracil | 1.87e-04 | 12 | 39 | 2 | CID002734394 | |
| Drug | AC1MHGAG | 1.87e-04 | 12 | 39 | 2 | CID003025954 | |
| Drug | Exosurf | 2.06e-04 | 67 | 39 | 3 | CID000071388 | |
| Drug | 1ct8 | 2.15e-04 | 173 | 39 | 4 | CID000444888 | |
| Drug | tryptophan-leucine | 2.20e-04 | 13 | 39 | 2 | CID000323786 | |
| Drug | maslinic acid | 2.20e-04 | 13 | 39 | 2 | CID000073659 | |
| Drug | F 1394 | 2.57e-04 | 14 | 39 | 2 | CID000178067 | |
| Drug | Rubidium chromate | 2.77e-04 | 74 | 39 | 3 | CID000061605 | |
| Drug | AC1Q6AQ7 | 2.95e-04 | 188 | 39 | 4 | CID000005515 | |
| Drug | BMY 42393 | 2.96e-04 | 15 | 39 | 2 | CID000131961 | |
| Drug | AC1L4Q08 | 2.96e-04 | 15 | 39 | 2 | CID000161747 | |
| Drug | 4-META | 2.96e-04 | 15 | 39 | 2 | CID000051027 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 3.14e-04 | 191 | 39 | 4 | 4442_UP | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.20e-04 | 192 | 39 | 4 | 3164_DN | |
| Drug | Vincamine [1617-90-9]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.26e-04 | 193 | 39 | 4 | 4341_UP | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 4950_DN | |
| Drug | oleoylcarnitine | 3.38e-04 | 16 | 39 | 2 | CID006441392 | |
| Drug | Amino nucleoside | 3.38e-04 | 16 | 39 | 2 | CID003000338 | |
| Drug | Bumetanide | 3.38e-04 | 16 | 39 | 2 | ctd:D002034 | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 2884_DN | |
| Drug | oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA | 3.39e-04 | 195 | 39 | 4 | 863_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 4406_UP | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Up 200; 10uM; PC3; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 6592_UP | |
| Drug | sodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A | 3.53e-04 | 197 | 39 | 4 | 407_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 3930_DN | |
| Drug | Imidurea [39236-46-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 5481_DN | |
| Drug | Delcorine; Up 200; 8.4uM; HL60; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 2178_UP | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 3259_DN | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6304_UP | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 5498_DN | |
| Drug | Meropenem [96036-03-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 5824_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 2769_DN | |
| Drug | clinofibrate | 3.83e-04 | 17 | 39 | 2 | CID000002787 | |
| Drug | 1bn3 | 3.83e-04 | 17 | 39 | 2 | CID000001514 | |
| Drug | MEDICA 16 | 3.83e-04 | 17 | 39 | 2 | CID000121871 | |
| Drug | thiocyanate | 4.16e-04 | 85 | 39 | 3 | CID000000781 | |
| Drug | 2-azetidinone | 4.30e-04 | 18 | 39 | 2 | CID000136721 | |
| Drug | 2-hydroxyursolic acid | 4.30e-04 | 18 | 39 | 2 | CID000155934 | |
| Drug | 1bnn | 4.80e-04 | 19 | 39 | 2 | CID000001604 | |
| Drug | Phosphoaminophosphonic Acid-Adenylate Ester | 4.80e-04 | 19 | 39 | 2 | DB04395 | |
| Drug | Beauvericin | 4.80e-04 | 19 | 39 | 2 | CID000105014 | |
| Drug | gemcabene | 5.33e-04 | 20 | 39 | 2 | CID000157691 | |
| Drug | NOC-9 | 5.88e-04 | 21 | 39 | 2 | CID000004524 | |
| Drug | estradiol-17 beta benzoate | 6.46e-04 | 22 | 39 | 2 | CID000066420 | |
| Drug | AC1L2Q3W | 6.46e-04 | 22 | 39 | 2 | CID000126312 | |
| Drug | AC1MTXUO | 6.46e-04 | 22 | 39 | 2 | CID003632206 | |
| Drug | Finish | 7.07e-04 | 23 | 39 | 2 | CID000086133 | |
| Drug | magnesium oxide | 7.07e-04 | 23 | 39 | 2 | CID000014792 | |
| Drug | CI-976 | 7.07e-04 | 23 | 39 | 2 | CID000122327 | |
| Disease | cholesteryl ester 24:4 measurement | 2.24e-05 | 7 | 31 | 2 | EFO_0021447 | |
| Disease | cholesteryl ester 24:5 measurement | 7.00e-05 | 12 | 31 | 2 | EFO_0021448 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 3.16e-04 | 25 | 31 | 2 | EFO_0010556 | |
| Disease | epilepsy (implicated_via_orthology) | 6.64e-04 | 163 | 31 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | Peripheral Nervous System Diseases | 1.48e-03 | 54 | 31 | 2 | C4721453 | |
| Disease | essential hypertension, age at diagnosis | 1.59e-03 | 56 | 31 | 2 | EFO_0004918, MONDO_0001134 | |
| Disease | sodium measurement | 5.25e-03 | 103 | 31 | 2 | EFO_0009282 | |
| Disease | acne | 7.64e-03 | 125 | 31 | 2 | EFO_0003894 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGQDRYRRRYWVLPY | 1116 | Q9UIF9 | |
| YYNIRPADSRWVRDP | 611 | Q9NWN3 | |
| HPQRFYPISYREWRR | 256 | Q9UNA3 | |
| NGLPDWRQPVFYYRR | 131 | Q96KC8 | |
| FRRPSRVHYYRPLTE | 196 | Q8N123 | |
| LPRAYYRWTRAHDLR | 791 | Q6IWH7 | |
| WEYFRLRPLRFRAPD | 501 | Q8IVT2 | |
| RSTYYWPRPRRYVQP | 6 | P0DTW1 | |
| RSTYYWPRPRRYVQP | 6 | O76087 | |
| DRNPAVYRRYFHWRR | 476 | P22083 | |
| RNRPHPFRARITYWG | 181 | Q9HAT1 | |
| QIRPWYTPRSSYREA | 36 | O75325 | |
| PRAPALRWNTTYRRY | 171 | Q76MJ5 | |
| RSTYYWPRPRRYVQP | 6 | Q4V326 | |
| IITWHRYRPPDYRDL | 506 | P08069 | |
| PRIGWYNRFARHPYY | 251 | Q4G148 | |
| PLWRHWRRETYPYYD | 31 | Q68DD2 | |
| WPHRYLTYRYFPRRR | 106 | Q17RF5 | |
| RSTYYWPRPRRYVQP | 6 | A1L429 | |
| RSTYYWPRPRRYVQP | 6 | P0CL80 | |
| RSTYYWPRPRRYVQP | 6 | P0CL81 | |
| RSTYYWPRPRRYVQP | 6 | A6NDE8 | |
| RSTYYWPRPRRYVQP | 6 | P0CL82 | |
| RSTYYWPRPRRYVQP | 6 | Q13070 | |
| RSTYYWPRPRRYVEP | 6 | Q4V321 | |
| RSTYYWPRPRRYVQP | 6 | Q13069 | |
| LLRTPNWRPRFRYYH | 666 | Q9UHW9 | |
| YRDWRRHLPSGPERY | 106 | Q8IW40 | |
| GWARRFVVVRRPYAY | 1591 | Q12756 | |
| PPERQWARFYVKIYR | 411 | Q9HC10 | |
| RTPNWRPRFRYYHWT | 606 | Q9H2X9 | |
| FPPLYYRRAHRRFVT | 191 | P82914 | |
| LIYRDSYPRNPTVRW | 306 | P35610 | |
| FYSSPLFRSLRPRWH | 371 | Q6UX01 | |
| RSTYYWPRPRRYVQP | 6 | P0DSO3 | |
| LLRTPNWRPRFKYYH | 601 | Q9UP95 | |
| IYRETYPRTPYVRWN | 281 | O75908 | |
| HRWVQYDGRIPYPRP | 381 | O95025 | |
| RRWCPPPFFYRRRFV | 221 | Q9Y2T7 | |
| PDRPRWDRCRYYHDR | 1051 | Q9H9J4 | |
| WINPLRRYRPFARSH | 1526 | Q9BX84 | |
| GTRVYSPPEWIRYHR | 206 | Q86V86 | |
| RQHARTLWYDRPRYV | 46 | E9PB15 | |
| RPPPRWVRGEHYRYK | 506 | Q96S06 |